David Kalwinsky

David Kalwinsky, MD

Tri-Cities Affiliate Clinic
Clinic Physician

Professor, Department of Pediatrics
East Tennessee State University, Quillen College of Medicine


Contact Information

Johnson City Medical Center
400 N State of Franklin Road
Johnson City, TN 37604
Phone: (423) 431-3950
Fax: (423) 431-3969


Education

Pediatric Hematology/Oncology Fellow, St Jude Children’s Hospital, Memphis, TN
Research Associate, National Institute of Health, National Cancer Institute, Bethesda MD
Medical Degree, University of Pennsylvania, PA
BA, Temple University


Background

1977-1990 – Hematology-Oncology Department, St. Jude Children’s Research Hospital


Professional Memberships

American Academy of Pediatrics
American Society of Clinical Oncology (ASCO)
American Society of Pediatric Hematology/Oncology (ASPHO)
American Society of Hematology (ASH)
Association of Medical School Department Chairs (AMSPDC)
Tennessee Pediatric Society
Society for Pediatric Research


Clinical/Research Interests


Selected Publications

Sandlund J, Kaston M, Kennedy W, Behm F, Kalwinsky D, Pui C, Raimondi S. A subtle 5(3;8) translocation results in juxtaposition of myc 1 BCL in a child with Burkitt Lymphoma and ataxia teleangectasia. Cancer Genet Cytogent 168:69-72, 2006.

Kalwinsky D. Health issues in the child with chronic illness transitions to adulthood. (Survivors of Prematurity, Survivors of Childhood Cancer, when Children with ADHA Become Adults, Type 2 Diabetes Mellitus, Selected Community Resources, selected book). Guest Editor. Southern Medical Journal 95:966-1004, 2002.

Castellino S, Powers R, Kalwinsky D, DeVoe M. Abdominal rhabdiod tumor presenting as fetal hydrops: A case report. Journal of Pediatric Hematology-Oncology 23:258-259, 2001.

Evans W, Yuen Y, Bomgaars L, Coutre S, Holdsworth M, Janco R, Kalwinsky D, Keller F, Khatib Z, Margolin J, Murray J, Quinn J, Ravindranath Y, Ritchey k, Roberts W, Rogers Z, Schiff D, Steuber C, Tucci F, Kornegay N, Krynetski E, Relling M. Preponderance of Thiopurine S-Methyltransferase Deficiency and Heterozygosity Among Patients Intolerant to Mercaptopurine or Azathioprine. Journal of Clinical OncologyApril 15; 19(8):2293-2301, 2001.

Kalwinsky DK. Malignant tumors of children and adolescents. In Chabner, B.A. (ed). Cancer Chemotherapy and Biological Response Modifiers Annual 15. Elsevier Press, Chapter 21, 646-664, 1994.

Kalwinsky D. Therapy for Acute Leukemias in Children. In Abeloff Current Opinion in Oncology 3:39-43, 1991.

Kalwinsky DK, Raimondi SC, Schell MJ, Behm FG and Mirro J. Cytogenetic abnormalities in childhood AML. In, Gale, R. (ed): UCLA Symposium on Acute Myelogenous Leukemia. Wiley-Less, Inc. New York, 1990.

Kalwinsky DK. Diagnostic importance of cytogenetic subgroups in acute nonlymphocytic leukemia. Haemotol Digest 5:16-17, 1990.

Kalwinsky DK, Raimondi SC, Bunin NJ, Fairclough D, Pui C-H, Relling MV, Riberio R, and Rivera GK. Clinical and biological features of acute lymphocytic leukemia in children with Down syndrome. Am J Med Genetics 37:267-271, 1990.

Dahl GV, Kalwinsky DK, Mirro J, Look AT, Pui C-H, Murphy SB, Mason C, Ruggierio M, Schell M, Johnson FL, Thomas ED. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 8:95-303, 1990.

Kalwinsky DK, Raimondi SC, Schell MJ, Mirro J, Santana VM, Behm F, Dahl GV and Williams D. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 8:75-83, 1990.

Rivera GK, Kalwinsky DK, Mirro J, Pui C-H, Abromowitch M, Ochs J, Furman W, Santana V, Look AT, and Dow LW. Intensified chemotherapy for childhood lymphoblastic leukemia: Modifications anduction treatment in St. Jude Study XI. Ann Pediatr 29:83-8, 1988.

Shenep JL, Kalwinsky DK, Hutson PR, George SL, Dodge RK, Blankenship KR, and Thorton D. Efficacy of oral sulcrafole suspension in the prevention and treatment of chemotherapy-induced mucositis. J Peds 113:758-763, 1988.

Kalwinsky D, Mirro J, Schell M, Behm F, Mason C, and Dahl GV. Early intensification of chemotherapy for childhood acute nonlymphocytic leukemia: improved remission induction with a 5-drug regimen including etoposide. J Clin Oncol 6:1134-1143, 1988.